Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-05-17 4:15 pm Purchase | 13G | F-STAR THERAPEUTICS INC FSTX | Boxer Capital LLC | 1,501,428 8.2% | 1,501,428 (New Position) | View |
| 2021-05-03 4:30 pm Purchase | 13D | RAIN ONCOLOGY INC. RAIN | Boxer Capital LLC | 1,894,192 9.99% | 1,894,192 (New Position) | View |
| 2021-04-30 4:45 pm Purchase | 13G | BIOMEA FUSION INC BMEA | Boxer Capital LLC | 2,088,405 7.3% | 2,088,405 (New Position) | View |
| 2021-02-26 4:40 pm Purchase | 13G | TALIS BIOMEDICAL CORP COM TLIS | Boxer Capital LLC | 1,550,998 6% | 1,550,998 (New Position) | View |
| 2021-02-16 5:29 pm Purchase | 13G | CABALETTA BIO INC CABA | Boxer Capital LLC | 1,603,361 6.7% | 37,000 (+2.36%) | View |
| 2021-02-16 5:17 pm Sale | 13G | Trillium Therapeutics Inc. TRIL | Boxer Capital LLC | 0 0% | -4,425,000 (Position Closed) | View |
| 2021-02-16 5:13 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Boxer Capital LLC | 6,200,261 9.9% | 2,998,572 (+93.66%) | View |
| 2021-02-16 5:10 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Boxer Capital LLC | 1,840,000 4% | 908,236 (+97.47%) | View |
| 2021-02-16 5:06 pm Purchase | 13G | ATRECA INC BCEL | Boxer Capital LLC | 2,202,333 7.3% | 468,750 (+27.04%) | View |
| 2021-02-16 5:01 pm Purchase | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Boxer Capital LLC | 11,478,634 5.8% | 1,290,322 (+12.66%) | View |
| 2021-02-16 4:57 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 2,477,194 8.3% | 700,000 (+39.39%) | View |
| 2021-02-16 4:53 pm Purchase | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Boxer Capital LLC | 3,767,299 6.8% | 575,000 (+18.01%) | View |
| 2021-02-16 4:50 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Boxer Capital LLC | 3,309,264 4.6% | 49,500 (+1.52%) | View |
| 2021-02-16 4:43 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | Boxer Capital LLC | 2,084,883 3.2% | -937,508 (-31.02%) | View |
| 2021-02-16 4:37 pm Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Boxer Capital LLC | 265,743 4.99% | -4,867,857 (-94.82%) | View |
| 2021-02-16 4:29 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 10,309,250 9.1% | -10,052,625 (-49.37%) | View |
| 2021-02-16 4:22 pm Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Boxer Capital LLC | 2,358,005 4.99% | -405,564 (-14.68%) | View |
| 2021-01-20 4:31 pm Purchase | 13G | MERUS N V COM MRUS | Boxer Capital LLC | 1,600,000 5.5% | 1,600,000 (New Position) | View |
| 2020-12-18 07:22 am Purchase | 13G | ARS PHARMACEUTICALS, INC SPRY | Boxer Capital LLC | 1,675,377 4.8% | 3 (+0.00%) | View |
| 2020-12-17 4:37 pm Purchase | 13G | ARS PHARMACEUTICALS, INC SPRY | Boxer Capital LLC | 1,675,374 4.8% | 1,675,374 (New Position) | View |